Versant's latest biotech focuses on inflammatory diseases

Versant Ventures' biotech incubation team has launched another Swiss startup, this time focused on a pair of antibodies for autoimmune and inflammatory diseases. Granite Bio broke cover on Thursday morning after raising a $30 million ...

Related Posts

Comments

Name

Email

Comment

Post Comment